(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NET NEUROENDOCRINE TUMOR RESEARCH FOUNDATION DEDICATED TO CURING NEUROENDOCRINE CANCER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NET NEUROENDOCRINE TUMOR RESEARCH FOUNDATION DEDICATED TO CURING NEUROENDOCRINE CANCER

ST13

US500000086728083

Class

35, 36, 44

Filing

86728083

Registration

5051112

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

05/26/2026

Trademark type

Combined

Nice classes

35, 36, 44

Filing date

08/18/2015

Registration date

09/27/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/02/2026

Last transaction

05/26/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/20/2015

First use in commerce

10/20/2015

Drawing code

3

Owner type

03

Owner location

Quincy, MA, US

Examiner

SMIGA, HOWARD

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "NET" in interconnected teal lettering, with the diagonal line of the letter "N" passing through a stylized dark gray microscope. The mark further consists of the phrase "NEUROENDOCRINE TUMOR RESEARCH FOUNDATION" in dark gray lettering below the word "NET". A teal line is positioned beneath the phrase "NEUROENDOCRINE TUMOR RESEARCH FOUNDATION", and the phrase "DEDICATED TO CURING NEUROENDOCRINE CANCER" in gray lettering is positioned beneath the teal line.

Holders and representatives

Holders

NEUROENDOCRINE TUMOR RESEARCH FOUNDATION, INC.
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION, INC.
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION, INC.
Caring for Carcinoid Foundation, Inc.

Representatives

Michelle Hon Donovan Duane Morris LLP

Technical classification

Nice Classes

Class 35Class 36Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting public awareness of carcinoidpancreaticrelated neuroendocrine cancers; providing a website featuring information regarding events promoting public awareness of carcinoidpancreaticrelated neuroendocrine cancers

Class 36

Charitable fund raising; accepting and administering monetary charitable contributions to fund carcinoidpancreaticrelated neuroendocrine cancer research

Class 44

Providing a website featuring information regarding carcinoidpancreaticrelated neuroendocrine cancers including preventionscreeningdiagnosisresearchtreatmenttherapies

Publications

History of USPTO decisions and trademark events.

33 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/02/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/02/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/02/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/02/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

02/27/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/27/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/29/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/29/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/29/2023

E815

TEAS SECTION 8 & 15 RECEIVED

09/19/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/27/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/27/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/20/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/19/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/17/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/16/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/06/2016

IUAF

USE AMENDMENT FILED

07/12/2016

EISU

TEAS STATEMENT OF USE RECEIVED

07/12/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/19/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/23/2016

PUBO

PUBLISHED FOR OPPOSITION

02/23/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/04/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/03/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

12/02/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/02/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

12/02/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/02/2015

DOCK

ASSIGNED TO EXAMINER

12/02/2015

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/22/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/21/2015

NWAP

NEW APPLICATION ENTERED

08/21/2015

Continuous trademark protection

Get notified about every new filing that threatens NET NEUROENDOCRINE TUMOR RESEARCH FOUNDATION DEDICATED TO CURING NEUROENDOCRINE CANCER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.